ClinicalTrials.Veeva

Menu

Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients

A

Associacao Fundo de Incentivo a Psicofarmcologia

Status

Unknown

Conditions

Obstructive Sleep Apnea Syndrome
Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT01455077
STD obesity
CEP0290/11
Portable monitoring system for

Details and patient eligibility

About

Introduction The portable monitoring system (PMS) recording of cardiopulmonary parameters (level III of ASDA) has been validated in subjects with high probability of Obstructive Sleep Apnea (OSA) without comorbidities.

However, there is not any study evaluating this system when OSA is associated with morbid obesity, so the validation of PMS will be very useful in order to properly work-up this highly risk population.

Objective:

To evaluate the accuracy of level III type of PMS - Stardust™" (STD), on patients with level II and III of obesity and high clinical suspicion of OSA.

Methods:Participants with BMI > 35 kg/m2 and with suspicion of OSA will consecutively be selected from an Outpatients Sleep Clinic of UNIFESP. They will be randomized for the following order of recordings:

  1. STD at home for 1 night 2) STD in the sleep lab simultaneous to PSG. AHI will be taken for subsequent analysis:a) AHI PSG b) AHI STD -lab and c) AHI STD- home.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI > 35
  • Complaints of snoring, sleep apnea, daytime sleepiness

Exclusion criteria

  • use of home oxygen
  • other sleep diseases
  • inability to perform PSG

Trial design

40 participants in 1 patient group

Obese patients
Description:
BMI \> 35

Trial contacts and locations

1

Loading...

Central trial contact

Lia R Bittencourt, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems